Drug Library

Showing 361–372 of 475 results

  • Glutamine

    Colestipol

    【Product name】Colestid Flavored

    [English common name]Colestipol

    [Chinese common name]Colestipol

    [English name]Cholestabyl, Colestipolum

    [Chinese other name]Jiangdanning, lipid-lowering resin II

    [Indications] This drug is also an anion exchange resin like cholestyramine. Its gastrointestinal effect is similar to cholestyramine. If the effective dose is the same, its adverse reactions and its interactions are also related to cholestene. The amine phase is similar. Cholestyramine is used for type II hyperlipidemia, atherosclerosis, and cirrhosis caused by cirrhosis and cholelithiasis.

    [Usage and Dosage] Usage:
    (1) Treatment of atherosclerosis: 3 times a day, each dose of powder 4-5g.
    (2) Itching: At the beginning, the amount of 6 to 10 g on the first day, the maintenance amount is 3 g per day, and the service is divided into 3 times.

    [Storage]Shading and confined storage.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Chronic gout

    Polyethylene glycol monododecyl ether

    【Product name】ASCLERA

    [English common name]Hexathylene Glycol Monododecyl Ether

    [Chinese common name]Polyethylene glycol monododecyl ether

    [English name]

    [Chinese other name]

    [Indications] Uncomplicated spider veins (varicose vein diameter ≤ 1 mm) and uncomplicated reticular structures of lower extremity veins (varices of 1 to 3 mm in diameter).

    [Usage and dosage] only for intravenous injection. The strength and volume of the solution is injected depending on the size and extent of the varicose veins. Extensive varicose veins may require multiple treatments. Spider vein (varicose vein diameter ≤ 1mm): Asclera 0.5%. Reticular veins (varicose veins 1 to 3 mm in diameter): 1% using Asclera. Intravenous injections of 0.1 to 0.3 ml per injection. The maximum recommended amount for each treatment is 10 ml.

    [Storage]2-8oC.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • other

    Polydoxol

    【Product name】Asclera

    [English common name]Polidocanol

    [Chinese common name]Polyethylene glycol monododecyl ether

    [English name]Laureth-9

    [Chinese other name]

    [Indications] Sclerotherapy for varicose veins, venous malformations, hemangioma, internal hemorrhoids, cystic diseases, etc.

    [Usage and Dosage] Single dose and daily dose
    The liquid therapeutic dose should generally not exceed 2 mg of polydoxol per kilogram of body weight per day. (For a patient weighing 70 kg, this is equivalent to no more than 14 ml of polydoxol injection per day (1%).)
    However, the actual dose administered is usually lower than the prescribed maximum dose.
    Extensive varices should be treated in a number of treatments.
    When a patient with an allergic reaction is first treated, one or more injections should not be given. In the subsequent course of treatment, if the maximum dose is not exceeded, several injections may be administered depending on the reaction.
    (1) Central venous sclerotherapy for spider vein-like veins
    Depending on the size of the area to be treated, 0.1-0.2 ml of liquid polydoxol injection (1%) was injected intravascularly each time.
    (2) Retinal sclerotherapy
    Depending on the size of the area to be treated, 0.1-0.3 ml of liquid polydoxol injection (1%) was injected intravascularly each time.
    (3) treatment of varicose veins
    Depending on the size of the area to be treated, 0.1-0.3 ml of liquid polydoxol injection (1%) was injected intravascularly each time.
    Administration method and duration of administration
    Injections are generally only made when the calf is placed horizontally or raised from the horizontal plane by about 30-45°.
    All injections must be administered intravenously, including a spider-like intravenous injection.
    Use a very fine needle (for example, an insulin needle) and a smooth moving syringe. Perform a tangential puncture, slow injection and ensure that the needle is always in the vein.
    Depending on the degree of varicose veins, it may take several more treatments.
    Note: Occasional varicose vein thrombosis is removed by knife removal and thrombus extrusion.
    A tight pressure bandage or elastic stocking must be applied after the compression treatment after injection of the liquid polydoxol injection (1%) covers the injection site. Thereafter, the patient should walk for 30 minutes, preferably within the treatment area.
    The pressure treatment time is 5-7 days. For a wide range of varicose veins, it is recommended to use a low tension bandage for a few months of compression.
    To ensure that the bandage does not slip, especially around the thigh and conical limbs, it is recommended to have a foam bandage support under the actual pressure bandage.
    The success of sclerotherapy depends on thorough and careful post-injection compression therapy.

    [Storage]Stored at 15-30 ° C; (59-86 °F).

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Familial spastic paraplegia

    Botulinum toxin

    【Product name】XEOMIN

    [English common name]incobotulinumtoxinA

    [Chinese common name]Botulinum toxin

    [English name]BTX, Botulinum Toxin

    [Chinese other name]Net good, angel bot

    [Indications] Eyelids, hemifacial spasms and related disorders of dystonia.

    [Usage and Dosage] The recommended dose of this product should not be interchanged with the dose of other Clostridium botulinum toxin preparations. This product must be used by a physician with appropriate qualifications and experience in treatment, and with appropriate equipment. The optimal effective dose and the optimal number of injection sites per muscle have not yet been established, so individual treatment regimens should be developed by the physician and the optimal dose should be determined by titration. Ailigen will assist in the training of this product injection technology. The recommended dose range for each injection site is 0.05-0.1 ml (eyelid, hemifacial spasm). See the following dilution table. Injection of this product with a sterile, 27-30/0.40-0.30mm needle does not necessarily require EMG monitoring. The recommended initial injection dose for the lateral part of the medial and lateral parts of the upper orbital iliac muscle of the upper eyelid iliac muscle is 1.25-2.5 U. If the eyebrows, the lateral aspect of the orbicularis and the upper facial area affect visual acuity, the injection site should also be increased at the corresponding site. Avoiding injections close to the upper eyelid side can reduce complications of drooping eyelids. Avoid the injection of the inside of the lower eyelid to reduce the spread of the oblique muscle, which can reduce the complications of double vision. The lower icon shows the injection reference site: it takes effect within three days after the general injection and reaches a peak in 1-2 weeks. Each treatment lasts for approximately 3 months and can be repeated as needed. When repeating treatment, if the initial therapeutic dose is considered insufficient, the injected dose can be increased or even doubled. However, if an injection site dose exceeds 5.0 U, there will be no better effect. The initial therapeutic dose per eye should not exceed 25U. In general, treatment frequencies greater than once every 3 months are not beneficial to the patient. When treating eyelids, the total dose per 12 weeks should not exceed 100U. Hemifacial spasm and VII pairs of patients with abnormal brain function, treatment of patients with unilateral orbital, and other affected facial muscles can be injected as needed. If the first treatment fails, ie one month after the injection, there is no significant clinical improvement compared to before treatment, the following measures should be taken: • Clinical validation, including specialists performing an EMG examination of the blockade of injected muscle; • Analysis failure Causes such as: improper selection of injected muscles, insufficient injection dose, lack of injection technique, occurrence of fixed muscle contracture, antagonism of muscle weakness, neutralization of toxin antibody formation, etc.; • Re-evaluation of treatment with Clostridium botulinum toxin type A; • If the first treatment is not effective, the following measures can be taken for the second treatment:
    (1) Analyze the cause of the first treatment failure and adjust the dose;
    (2) Injection under EMG monitoring;
    (3) There is a three-month interval between the two treatments. If the reinjection treatment fails or is not effective, consider replacing the treatment. How to use, handle and dispose of this product: It is recommended to carry out the dilution operation and the preparation of the syringe on the paper towel with plastic liner to prevent the liquid from splashing. The product was diluted with sterile, preservative-free saline (0.9% sodium chloride for injection). Draw the appropriate amount of diluent with a syringe (see the dilution table below). Since the product will be denatured by the vibration of bubbles or similar forces, the diluent should be gently pushed into the bottle. If there is no vacuum suction in the bottle, the bottle should be discarded. After preparation, this product should be a clear liquid with no color to slightly yellow and no impurities. Before using the preparation solution, visually check the clarity and impurities. The preparation solution should be stored in the refrigerator (2 ° C - 8 ° C) for up to 4 hours. This product can only be used in a single use, and the remaining solution should be discarded. For safety reasons, unused vials should be filled with a small amount of water and then autoclaved; all used vials, syringes, and spilled liquids should be autoclaved or 0.5% hypochlorous acid. The salt solution inactivated the residue of the product for 5 minutes.

    [Storage] Store at 2oC~8oC in cold storage or below -5oC. After preparation: Store at 2oC~8oC in cold storage and use within 4 hours. Container: A 10 ml capacity type I colorless glass bottle with a rubber stopper and sealed with aluminum foil.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • other

    Botulinum toxin A

    【Product name】Dysport

    [English common name]Abobotulinumtoxin A

    [Chinese common name]Botulinum toxin A

    [English name]

    [Chinese other name]

    [Indications] Eyelids, hemifacial spasms and related disorders of dystonia.

    [Usage and Dosage] The recommended dose of this product should not be interchanged with the dose of other Clostridium botulinum toxin preparations. This product must be used by a physician with appropriate qualifications and experience in treatment, and with appropriate equipment. The optimal effective dose and the optimal number of injection sites per muscle have not yet been established, so individual treatment regimens should be developed by the physician and the optimal dose should be determined by titration. Ailigen will assist in the training of this product injection technology. The recommended dose range for each injection site is 0.05-0.1 ml (eyelid, hemifacial spasm). See the following dilution table. Injection of this product with a sterile, 27-30/0.40-0.30mm needle does not necessarily require EMG monitoring. The recommended initial injection dose for the lateral part of the medial and lateral parts of the upper orbital iliac muscle of the upper eyelid iliac muscle is 1.25-2.5 U. If the eyebrows, the lateral aspect of the orbicularis and the upper facial area affect visual acuity, the injection site should also be increased at the corresponding site. Avoiding injections close to the upper eyelid side can reduce complications of drooping eyelids. Avoid the injection of the inside of the lower eyelid to reduce the spread of the oblique muscle, which can reduce the complications of double vision. The lower icon shows the injection reference site: it takes effect within three days after the general injection and reaches a peak in 1-2 weeks. Each treatment lasts for approximately 3 months and can be repeated as needed. When repeating treatment, if the initial therapeutic dose is considered insufficient, the injected dose can be increased or even doubled. However, if an injection site dose exceeds 5.0 U, there will be no better effect. The initial therapeutic dose per eye should not exceed 25U. In general, treatment frequencies greater than once every 3 months are not beneficial to the patient. When treating eyelids, the total dose per 12 weeks should not exceed 100U. Hemifacial spasm and VII pairs of patients with abnormal brain function, treatment of patients with unilateral orbital, and other affected facial muscles can be injected as needed. If the first treatment fails, ie one month after the injection, there is no significant clinical improvement compared to before treatment, the following measures should be taken: • Clinical validation, including specialists performing an EMG examination of the blockade of injected muscle; • Analysis failure Causes such as: improper selection of injected muscles, insufficient injection dose, lack of injection technique, occurrence of fixed muscle contracture, antagonism of muscle weakness, neutralization of toxin antibody formation, etc.; • Re-evaluation of treatment with Clostridium botulinum toxin type A; • If the first treatment is not effective, the following measures can be taken for the second treatment:
    (1) Analyze the cause of the first treatment failure and adjust the dose;
    (2) Injection under EMG monitoring;
    (3) There is a three-month interval between the two treatments. If the reinjection treatment fails or is not effective, consider replacing the treatment. How to use, handle and dispose of this product: It is recommended to carry out the dilution operation and the preparation of the syringe on the paper towel with plastic liner to prevent the liquid from splashing. The product was diluted with sterile, preservative-free saline (0.9% sodium chloride for injection). Draw the appropriate amount of diluent with a syringe (see the dilution table below). Since the product will be denatured by the vibration of bubbles or similar forces, the diluent should be gently pushed into the bottle. If there is no vacuum suction in the bottle, the bottle should be discarded. After preparation, this product should be a clear liquid with no color to slightly yellow and no impurities. Before using the preparation solution, visually check the clarity and impurities. The preparation solution should be stored in the refrigerator (2 ° C - 8 ° C) for up to 4 hours. This product can only be used in a single use, and the remaining solution should be discarded. For safety reasons, unused vials should be filled with a small amount of water and then autoclaved; all used vials, syringes, and spilled liquids should be autoclaved or 0.5% hypochlorous acid. The salt solution inactivated the residue of the product for 5 minutes.

    [Storage] Store at 2oC~8oC in cold storage or below -5oC. After preparation: Store at 2oC~8oC in cold storage and use within 4 hours. Container: A 10 ml capacity type I colorless glass bottle with a rubber stopper and sealed with aluminum foil.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Beta-ketothiolase deficiency , Propionic acidemia

    Carnitine

    【Product name】L-Carn, NICETILE, Burgerstein

    [English common name]Carnitine

    [Chinese common name]Carnitine

    [English name]DL-Carnitine

    [Chinese other name]DL-carnitine

    [indications]
    L-carnitine weight loss capsule: slimming.
    L-carnitine tablets: promote fat burning, help to quickly break down the waist, abdomen, arms, accumulated fat, reshape the fascinating curve.

    【Dosage】
    L-carnitine slimming capsules: 2 times a day, 2 capsules each time.
    L-carnitine tablets: 2 tablets each time, 2 times a day, chewing or swallowing, drink plenty of water. It is recommended to use half an hour before exercise and half an hour before meal.

    [Storage]
    L-carnitine slimming capsule: sealed, placed in a cool dry place.
    L-carnitine tablets: sealed, placed in a cool dry place.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Prostate cancer

    Choline C11

    【Product name】CHOLINE

    [English common name]Choline C11

    [Chinese common name]Choline C11

    [English name]

    [Chinese other name]

    [indications] recurrenceProstate cancerDetection

    【Dosage】

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Dwarf syndrome , Congenital hyperinsulinemia

    insulin

    【Product name】Insulin, Ryzodeg, Tresiba, Xultophy, NOVOLIN, AFREZZA

    [English common name]Insulin

    [Chinese common name]insulin

    [English name]Insulin injection

    [Chinese other name]Insulin injection

    [indications]
    Humanized special insulin injection:
    1. For the treatment of type 1 diabetes in adults and children.
    2. Also available forType 2 diabetesPatients supplemented with long-acting insulin to control their hyperglycemia.
    Protamine zinc recombinant human insulin mixed injection: This product is mainly used to treat type I or type II diabetes.
    30/70 mixed recombinant human insulin injection: type I or type II diabetes.
    Low-protamine recombinant human insulin injection: This product is mainly used to treat type I or type II diabetes.
    50/50 mixed recombinant human insulin injection: type 1 or type 2 diabetes.
    Conventional recombinant human insulin injection: This product is suitable for the treatment of diabetic patients who need insulin to maintain blood sugar levels. It is also suitable for early treatment of early diabetic patients and for the treatment of diabetic patients during pregnancy.
    Recombinant insulin glargine injection: This product is suitable for diabetes.
    Adenine triphosphate coenzyme for injection: for the improvement of symptoms such as hepatitis, nephritis, cirrhosis, heart failure and the like.

    【Dosage】
    Humanized special insulin injection: subcutaneous injection, 1 or 2 times a day, the dose depends on the blood glucose concentration. Oral hypoglycemic drugs can not control type 2 diabetes, if the patient has not used insulin therapy, the initial dose of this product is 0.1 ~ 0.2U / kg, once a day, or 10U each time, 1 or 2 times a day. Dosage conversion is available for patients with type 1 and type 2 diabetes who are receiving general insulin therapy when switching to this product.
    Protamine zinc recombinant human insulin mixed injection: The clinician determines the therapeutic dose of insulin administered to the patient according to the actual demand of the patient. It should be administered by subcutaneous injection, although it is not recommended but can also be administered intramuscularly. It can not be administered by intravenous injection. The upper arm, thigh, buttocks or abdomen should be selected for subcutaneous injection. At the same time, attention should be paid to the rotation of the injection site. The number of injections per month for the same site should not exceed one. Care should be taken during injections to ensure that blood vessels are not pierced. When the injection is completed, the injection site cannot be sputum. Patients should be aware of the correct method of administration by injection. a) The preparation of the dose should be inverted 10 times in the hand and 10 times in the 180° before use to ensure that the insulin preparation shows a uniform turbid or milky state at the time of injection.
    30/70 mixed recombinant human insulin injection:
    Instructions:
    1. Check if the refill is consistent with the doctor's recommended specifications before use.
    2. Method of preparing insulin: According to the method of using Dongbao pen, correctly insert the refill into the refill holder, and then install the Dongbao needle. Slowly invert the Dongbao pen 8 to 10 times to make the liquid in the refill mix evenly. Turn the dose adjustment knob to adjust to the desired dose. After removing the needle cap and draining the air bubbles, you can inject it. Be careful not to touch the needle with anything during use to prevent contamination.
    3. Selection of injection site: The injection site should choose the looser part of the skin, such as the upper arm, thigh, buttocks and abdomen. The injection site should alternate in turn. The same site can not be injected twice in two weeks. Each injection site should be The last injection site was about 1 cm apart.
    Low-protamine recombinant human insulin injection:
    Instructions:
    1. This product is a white or off-white suspension. It is injected subcutaneously about 1 hour before breakfast and dinner. The specific time is determined by the doctor according to the patient's condition.
    2. Method of preparing insulin: first wash your hands, gently shake or turn the medicine bottle to mix the liquid evenly, and carefully check the appearance of the insulin taken, remove the plastic protective cap, expose the rubber stopper, use 75% alcohol Wipe the stopper, if using one type of insulin, inhale the syringe into the air equivalent to the insulin dose, insert the needle into the stopper, inject the air into the tube, invert the syringe and the vial, hold it with one hand and gently shake it. Make sure the top of the needle is below the liquid level and then use the other hand to push the pusher back to extract the correct amount. Check the tube for bubbles before withdrawing the needle.
    50/50 mixed recombinant human insulin injection:
    Instructions:
    1. Check if the refill is consistent with the doctor's recommended specifications before use.
    2. Method of preparing insulin: According to the method of using Dongbao pen, after installing the refill correctly into the refill holder, install the Dongbao needle. Slowly invert the Dongbao pen 8-10 times to make the liquid in the refill mix evenly. Turn the dose adjustment knob to adjust to the desired dose. After removing the needle cap and inserting the air bubbles, you can inject it. Be careful not to touch the needle with anything during use to prevent contamination.
    3. Selection of injection site: The injection site should choose the looser part of the skin, such as the arms, thighs, buttocks and abdomen, etc. The injection site should alternate in turn. The same part can not be injected continuously for two weeks within two weeks. The last injection site was about 1 cm apart.
    Conventional recombinant human insulin injection:
    1. This product is a white suspension. It is injected subcutaneously about 1 hour before breakfast and dinner. The specific time is determined by the doctor according to the condition.
    2. Method of using insulin: Be careful not to touch the needle number with any object during use to prevent contamination. If it is to be mixed with recombinant human insulin injection, it should be carried out under the guidance of a doctor. Before extracting recombinant human insulin, the vial should be placed in the palm of the hand and gently rolled until the insulin is in a uniform suspension. The same amount of low-protamine recombinant human insulin is extracted with a syringe, and the air is injected into the reconstitution. Inside the human insulin bottle, then pull the needle out. The same amount of air as the conventional recombinant human insulin is injected with a syringe, and the air is injected into a conventional recombinant human insulin bottle, and then the vial and the syringe are inverted.
    Recombinant insulin glargine injection:
    1. Usage.
    2. Insulin glargine has a long-acting effect, and can be injected subcutaneously once a day.
    3. Insulin glargine should be administered subcutaneously and return to room temperature before injection. Please follow the steps below when injecting,
    (1) Observe the appearance of the liquid in the bottle. Normally it should be a colorless clear solution. Do not continue to use if the appearance is cloudy, slight color changes, or visible particles.
    (2) Remove the plastic protective cap before using the new drug, but do not remove the stopper. Wipe the top of the bottle and the stopper with a 75% alcohol cotton ball before each use.
    (3) Draw the same amount of air as you need insulin glargine, insert the needle into the stopper and inject the air into the needle.
    (4) Hold the vial upside down with one hand.
    Injectable adenosine triphosphate coenzyme insulin: intravenous injection. Dilute with 25% glucose injection and slowly inject. Intravenous drip. After instillation with 500 ml of 5% glucose injection, the instillation was carried out. Intramuscular injection. After injecting 2 ml of sodium chloride injection, it was injected. One day, 2-6 weeks for a course of treatment.

    [Storage]
    Humanized special insulin injection: 2 ~ 8 ° C preservation, to avoid freezing. The opened injection can be stored for 42 days at 30 ° C or less.
    Protamine zinc recombinant human insulin mixed injection: sealed.
    30/70 mixed recombinant human insulin injection: This product should be stored in the refrigerator at 2 ~ 8 °C before use, do not freeze or close to the ice tray, frozen insulin can not be used, the refill stored in the insulin injection pen Do not store in the refrigerator, the patient can carry it for one month without being exposed to direct sunlight or hot drama.
    Low-protamine recombinant human insulin injection: sealed.
    50/50 mixed recombinant human insulin injection: This product should be stored in the refrigerator at 2-8 °C before use. The refill stored in the insulin injection pen should not be stored in the refrigerator. The patient can avoid direct sunlight or cold. Carry it with you for a month under the hot conditions.
    Conventional recombinant human insulin injection: confined preservation.
    Recombinant insulin glargine injection: sealed and stored.
    Injectable adenosine triphosphate coenzyme insulin: sealed, kept in a cool place (not more than 20 ° C).

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • other

    Clostridium collagenase

    【Product name】Xiaflex

    [English common name]

    [Chinese common name]Clostridium collagenase

    [English name]Collagenase

    [Chinese other name]

    [Indications] XIAFLEX is used to treat adult patients with Dupuytren contracture and can touch the umbilical cord.

    [Usage and Dosage] XIAFLEX should be managed by an experienced healthcare provider in the hand-injection procedure and Dupuytren's contracture treatment.
    Reconstitute the XIAFLEX lyophilized powder using only the supplied diluent before use.
    According to the injection procedure, 0.58 mg of XIAFLEX was injected into the accessible Dupuytren umbilical cord with a contraction of the metacarpophalangeal (MP) joint or the proximal interphalangeal (PIP) joint.
    About 24 hours after the injection, if the contracture continues, perform a finger stretching operation.
    The injection and finger extension procedures can be performed 3 times on each rope every 4 weeks or so.

    [Storage] Prior to reconstitution, vials of XIAFLEX and diluent should be stored in a 2o to 8oC (36o to 46oF) refrigerator [see Dosage and Administration]. Do not freeze.
    The recombinant XIAFLEX solution can be stored at room temperature (20o to 25oC/68o to 77oF) for 1 hour or at 2o to 8 ̊C (36o to 46°F) for at least 4 hours.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Ataxia - telangiectasia , Severe combined immunodeficiency

    Thymosin

    【Product name】ZADAXIN, THYMIN(RG)

    [English common name]Thymosin

    [Chinese common name]Thymosin

    [English name]Thymin

    [Chinese other name]Thymosin

    [indications]
    Chronic hepatitis B 
    This product is used to treat patients with chronic hepatitis B over the age of 18, and the patient's liver disease is compensatory and has hepatitis B virus replication (serum HBV-DNA positive), in those serum hepatitis B surface antigen (HBsAg) positive Studies in patients with a minimum of 6 months and elevated serum aminotransferase (ALT) have shown that treatment with this product can produce viral remission (serum HBV-DNA loss) and retransferase levels. In some responding patients, the drug treatment removes serum surface antigens. Clinical trials suggest that when this drug is combined with alpha interferon, it may have a higher response rate than the drug alone or with interferon alone.
    An immunopotentiator for immunocompromised patients 
    The immune system is inhibited, including those who receive chronic hemodialysis and elderly patients. This medicine can enhance the immune response of patients to viral vaccines such as influenza vaccine or hepatitis B vaccine. Studies on hemodialysis patients have shown that 65% of patients who took this drug as an adjuvant had an anti-influenza antibody titer level that increased more than four-fold after flu vaccine, and only 24% of patients in the placebo group responded.

    【Dosage】
    This product should not be used for intramuscular or intravenous injection. It should be subcutaneously injected immediately after dissolution with 1.0 ml of water for injection in the box. Dosages can be used as directed by your doctor.
    Chronic hepatitis B This product is recommended for the treatment of chronic hepatitis B. The subcutaneous injection of 1.6 mg per needle is twice a week, and the two doses are approximately 3-4 days apart. Treatment should be uninterrupted for 6 months (52 needles).
    If this product is used in combination with alpha interferon, the dose and precautions in the alpha interferon prescription data should be consulted. In a combined clinical trial, when the two drugs are used on the same day, the product is usually administered in the morning and the interferon is administered at night.
    As a vaccine booster for immunocompromised patients, this product is used as a viral vaccine enhancer. The recommended dose is 1.6mg subcutaneous injection, twice a week, 3 to 4 days apart, and the course of treatment should last 4 weeks (8 needles in total). The first needle should be given immediately after vaccination.
    The physician decides whether to teach the patient to self-inject.

    [Storage]Sealed, shading, stored at 2-8 ° C (36 ° ~ 46 ° F), immediately after preparation.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Severe combined immunodeficiency

    Adenosine deaminase (ADA)

    【Product name】Strimvelis, Adenosine Deaminase Antibody

    [English common name]Adenosine Deaminase

    [Chinese common name]Adenosine deaminase (ADA)

    [English name]ADA

    [Chinese other name]Adenine deaminase

    [indications]Strimvelis is available for the treatment of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA), a relevant stem cell donor who does not have a suitable human leukocyte antigen (HLA) match.

    【Dosage】
    Strimvelis must be performed by a professional transplant center, with ADA-SCID patient treatment and management experience and with a physician using autologous CD34 + ex vivo gene therapy products. Strimvelis should only be performed after consultation with patients and/or family members. Patients are expected to enter the post-treatment registry and will be followed for long-term follow-up.
    CD34+ stem cells containing at least 1 million CD34+ cells per kilogram are required for use. This should be harvested from the patient at least 3 weeks prior to treatment with Strimvelis. If the product is manufactured after treatment with Strimvelis, failure occurs during transplantation or long-term bone marrow dysplasia, the stem cells are collected for use as salvage therapy.
    Patients must be able to donate enough CD34+ cells to provide the minimum of 4 million purified CD34+ cells/kg required to make Strimvelis.
    Strimvelis is for self-use only. Prior to infusion, the patient's identity must be confirmed to match the basic unique patient information on the Strimvelis infusion bag and/or container.

    [Storage] shelf life of 6 hours, must be stored inAt 15-30 ° C.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Renal cell carcinoma (RCC) , Gastrointestinal stromal tumor (GIST)

    Sunitinib

    【Product name】Sutent

    [English common name]Sunitinib

    [Chinese common name]Sunitinib

    [English name]

    [Chinese other name]Sunitinib, sulindini base, sunitinib base

    [Indications] ImatinibGastrointestinal stromal tumorKidney resectable or metastaticRenal cell carcinoma, pancreatic neuroendocrine tumors.

    [Usage and Dosage] Imatinib resistant gastrointestinal stromal tumors, radical resectable or metastatic renal cell carcinoma adults, oral 50mg once a day, oral sunitinib for 4 weeks, and then discontinued for 2 weeks. In addition, the weight is reduced according to the condition of the patient. In adults with pancreatic neuroendocrine tumors, sunitinib is orally administered 37.5 mg daily. Depending on the condition of the patient, it may be increased or decreased as appropriate, but may be increased to 50 mg per day.

    [Storage] 2-8 degrees Celsius, protected from light and moisture, sealed and dry.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.